Al-Wakeel Yasir B.

CIK 00016506914 companiesROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001650691

Recent Transactions

35 trades

Award
MAXCYTE, INC.$MXCT
Common Stock
2026-06-17+30,421→ 80,998 total
Award
MAXCYTE, INC.$MXCT
Stock Option (right to buy)
2026-06-17+49,579→ 49,579 total
Award
MAXCYTE, INC.$MXCT
Common Stock
2025-06-18+29,210→ 50,577 total
Award
MAXCYTE, INC.$MXCT
Stock Option (right to buy)
2025-06-18+50,790→ 50,790 total
Award
MAXCYTE, INC.$MXCT
Common Stock
2024-06-11+21,367→ 21,367 total
Award
MAXCYTE, INC.$MXCT
Stock Option (right to buy)
2024-06-11+40,701→ 40,701 total
Sale
Kronos Bio, Inc.
Common Stock
2023-07-06$1.75/sh−9,617→ 346,102 total
Award
MAXCYTE, INC.$MXCT
Stock Option (right to buy)
2023-06-22+50,000→ 50,000 total
Award
MAXCYTE, INC.$MXCT
Stock Option (right to buy)
2023-03-20+40,000→ 40,000 total
Sale
Kronos Bio, Inc.
Common Stock
2023-02-24$1.74/sh−9,026→ 355,719 total
Award
Kronos Bio, Inc.
Common Stock
2023-02-15+138,911→ 364,745 total
Award
Kronos Bio, Inc.
Employee Stock Option (Right to Buy)
2023-02-15+208,367→ 208,367 total
Award
Kronos Bio, Inc.
Employee Stock Option (Right to Buy)
2022-07-25+40,000→ 40,000 total
Award
Kronos Bio, Inc.
Common Stock
2022-07-25+53,600→ 216,841 total
Award
MAXCYTE, INC.$MXCT
Stock Option (right to buy)
2022-06-29+26,900→ 26,900 total
Award
Kronos Bio, Inc.
Common Stock
2022-02-15+53,600→ 163,241 total
Award
Kronos Bio, Inc.
Employee Stock Option (Right to Buy)
2022-02-15+80,000→ 80,000 total
Award
MAXCYTE, INC.$MXCT
Stock Option (right to buy)
2021-08-09+10,000→ 10,000 total
Award
Kronos Bio, Inc.
Employee Stock Option (Right to Buy)
2020-12-09+108,633→ 108,633 total
Award
Kronos Bio, Inc.
Common Stock
2020-12-09+72,422→ 109,641 total
Purchase
Kronos Bio, Inc.
Common Stock
2020-10-14$19.00/sh+5,250→ 37,219 total
Disposition to Issuer
Neon Therapeutics, Inc.
Stock Option (Right to Buy)
2020-05-06−192,759→ 0 total
Disposition to Issuer
Neon Therapeutics, Inc.
Common Stock
2020-05-06−196,965→ 0 total
Disposition to Issuer
Neon Therapeutics, Inc.
Stock Option (Right to Buy)
2020-05-06−61,031→ 0 total
Disposition to Issuer
Neon Therapeutics, Inc.
Stock Option (Right to Buy)
2020-05-06−100,000→ 0 total
Tax Payment
Neon Therapeutics, Inc.
Common Stock
2020-02-29$1.50/sh−4,891→ 196,965 total
Tax Payment
Neon Therapeutics, Inc.
Common Stock
2020-02-25$1.51/sh−5,385→ 201,856 total
Award
Neon Therapeutics, Inc.
Common Stock
2020-01-12+65,000→ 207,241 total
Award
Neon Therapeutics, Inc.
Common Stock
2019-11-25+75,000→ 142,241 total
Award
Neon Therapeutics, Inc.
Common Stock
2019-02-27+50,000→ 67,241 total
Award
Neon Therapeutics, Inc.
Stock Option (Right to Buy)
2019-02-27+100,000→ 100,000 total
Exercise/Conversion
Neon Therapeutics, Inc.
Common Stock
2018-07-17$5.80/sh+17,241→ 17,241 total
Exercise/Conversion
Neon Therapeutics, Inc.
Stock Option (Right to Buy)
2018-07-17−17,241→ 192,759 total
Award
MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
2016-02-08+105,000→ 105,000 total
Award
MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
2015-08-11+300,000→ 300,000 total

Companies

Recent Filings

Address

C/O MAXCYTE, INC. 9713 KEY WEST AVENUE, SUITE 400

ROCKVILLE, MD, 20850

View on SEC.gov